Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2013 June;55(2) > Panminerva Medica 2013 June;55(2):175-89

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

  CUTTING EDGE RESPIRATORY MEDICINE 2013


Panminerva Medica 2013 June;55(2):175-89

Copyright © 2013 EDIZIONI MINERVA MEDICA

lingua: Inglese

Treatment of sarcoidosis

Baughman R. P.

Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA


PDF  


The treatment of pulmonary sarcoidosis is based on several factors. These include changes in pulmonary physiology, presence of extra-pulmonary disease, and symptoms. Several immunosuppressive agents have been studied and recommendations regarding the utility of these different agents have evolved. While glucocorticoids remain the most commonly used agent, other drugs have been used as steroid sparing and for those patients who progress despite routine treatment. Non immunosuppressive agents also play a role in the therapy of pulmonary sarcoidosis patients. These include treatments for pulmonary hypertension, infection, and fatigue.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

bob.baughman@uc.edu